BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 33460618)

  • 1. Antihypertensive Medication Classes and the Risk of Dementia: A Systematic Review and Network Meta-Analysis.
    den Brok MGHE; van Dalen JW; Abdulrahman H; Larson EB; van Middelaar T; van Gool WA; van Charante EPM; Richard E
    J Am Med Dir Assoc; 2021 Jul; 22(7):1386-1395.e15. PubMed ID: 33460618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lower dementia risk with different classes of antihypertensive medication in older patients.
    van Middelaar T; van Vught LA; Moll van Charante EP; Eurelings LSM; Ligthart SA; van Dalen JW; van den Born BJH; Richard E; van Gool WA
    J Hypertens; 2017 Oct; 35(10):2095-2101. PubMed ID: 28509727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. First-line drugs inhibiting the renin angiotensin system versus other first-line antihypertensive drug classes for hypertension.
    Xue H; Lu Z; Tang WL; Pang LW; Wang GM; Wong GW; Wright JM
    Cochrane Database Syst Rev; 2015 Jan; 1():CD008170. PubMed ID: 25577154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antihypertensive medication classes and risk of incident dementia in primary care patients: a longitudinal cohort study in the Netherlands.
    Schroevers JL; Hoevenaar-Blom MP; Busschers WB; Hollander M; Van Gool WA; Richard E; Van Dalen JW; Moll van Charante EP
    Lancet Reg Health Eur; 2024 Jul; 42():100927. PubMed ID: 38800111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative risk of new-onset diabetes mellitus for antihypertensive drugs in elderly: A Bayesian network meta-analysis.
    Zhang J; Tong A; Dai Y; Niu J; Yu F; Xu F
    J Clin Hypertens (Greenwich); 2019 Aug; 21(8):1082-1090. PubMed ID: 31241860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antihypertensive medication classes and the risk of dementia over a decade of follow-up.
    Schroevers JL; Eggink E; Hoevenaar-Blom MP; Van Dalen JW; Van Middelaar T; Van Gool WA; Richard E; Moll Van Charante EP
    J Hypertens; 2023 Feb; 41(2):262-270. PubMed ID: 36394298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antihypertensive treatment and risk of cancer: an individual participant data meta-analysis.
    Copland E; Canoy D; Nazarzadeh M; Bidel Z; Ramakrishnan R; Woodward M; Chalmers J; Teo KK; Pepine CJ; Davis BR; Kjeldsen S; Sundström J; Rahimi K;
    Lancet Oncol; 2021 Apr; 22(4):558-570. PubMed ID: 33794209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antihypertensive drugs and risk of cancer: network meta-analyses and trial sequential analyses of 324,168 participants from randomised trials.
    Bangalore S; Kumar S; Kjeldsen SE; Makani H; Grossman E; Wetterslev J; Gupta AK; Sever PS; Gluud C; Messerli FH
    Lancet Oncol; 2011 Jan; 12(1):65-82. PubMed ID: 21123111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative effectiveness of renin-angiotensin system blockers and other antihypertensive drugs in patients with diabetes: systematic review and bayesian network meta-analysis.
    Wu HY; Huang JW; Lin HJ; Liao WC; Peng YS; Hung KY; Wu KD; Tu YK; Chien KL
    BMJ; 2013 Oct; 347():f6008. PubMed ID: 24157497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beta-blockers for hypertension.
    Wiysonge CS; Bradley HA; Volmink J; Mayosi BM; Opie LH
    Cochrane Database Syst Rev; 2017 Jan; 1(1):CD002003. PubMed ID: 28107561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antihypertensive Medication Class and the Risk of Dementia and Cognitive Decline in Older Adults: A Secondary Analysis of the Prospective HELIAD Cohort.
    Liampas I; Hatzimanolis A; Siokas V; Yannakoulia M; Kosmidis MH; Sakka P; Hadjigeorgiou GM; Scarmeas N; Dardiotis E
    J Alzheimers Dis; 2022; 89(2):709-719. PubMed ID: 35912747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of Major Antihypertensive Drug Classes on Erectile Function: a Network Meta-analysis.
    Farmakis IT; Pyrgidis N; Doundoulakis I; Mykoniatis I; Akrivos E; Giannakoulas G
    Cardiovasc Drugs Ther; 2022 Oct; 36(5):903-914. PubMed ID: 33945044
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Health outcomes associated with various antihypertensive therapies used as first-line agents: a network meta-analysis.
    Psaty BM; Lumley T; Furberg CD; Schellenbaum G; Pahor M; Alderman MH; Weiss NS
    JAMA; 2003 May; 289(19):2534-44. PubMed ID: 12759325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beta-blockers for hypertension.
    Wiysonge CS; Bradley H; Mayosi BM; Maroney R; Mbewu A; Opie LH; Volmink J
    Cochrane Database Syst Rev; 2007 Jan; (1):CD002003. PubMed ID: 17253471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calcium channel blockers versus other classes of drugs for hypertension.
    Chen N; Zhou M; Yang M; Guo J; Zhu C; Yang J; Wang Y; Yang X; He L
    Cochrane Database Syst Rev; 2010 Aug; (8):CD003654. PubMed ID: 20687074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological interventions for hypertension in children.
    Chaturvedi S; Lipszyc DH; Licht C; Craig JC; Parekh R
    Evid Based Child Health; 2014 Sep; 9(3):498-580. PubMed ID: 25236305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The relationships between antihypertensive medications and the overall survival of patients with pancreatic cancer: a systematic review and meta-analysis.
    Jiang W; He R; Lu Y; Zhou W
    Expert Rev Gastroenterol Hepatol; 2022 Jun; 16(6):547-553. PubMed ID: 35686669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of different antihypertensive medication groups on cognitive function in older patients: A systematic review.
    Stuhec M; Keuschler J; Serra-Mestres J; Isetta M
    Eur Psychiatry; 2017 Oct; 46():1-15. PubMed ID: 28992530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How does exercise treatment compare with antihypertensive medications? A network meta-analysis of 391 randomised controlled trials assessing exercise and medication effects on systolic blood pressure.
    Naci H; Salcher-Konrad M; Dias S; Blum MR; Sahoo SA; Nunan D; Ioannidis JPA
    Br J Sports Med; 2019 Jul; 53(14):859-869. PubMed ID: 30563873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ACE Inhibitor Benefit to Kidney and Cardiovascular Outcomes for Patients with Non-Dialysis Chronic Kidney Disease Stages 3-5: A Network Meta-Analysis of Randomised Clinical Trials.
    Zhang Y; He D; Zhang W; Xing Y; Guo Y; Wang F; Jia J; Yan T; Liu Y; Lin S
    Drugs; 2020 Jun; 80(8):797-811. PubMed ID: 32333236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.